Stocks of Zomedica Corp (AMEX:ZOM) traded higher last session on Wall Street, down -2.27% to $0.17.
According to the data, Zomedica Corp (AMEX:ZOM) has 1 analysts covering its stock. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $0.44 and a low of $0.44, we find $0.44. Given the previous closing price of $0.17, this indicates a potential upside of 158.82 percent. ZOM stock price is now -1.78% away from the 50-day moving average and -17.60% away from the 200-day moving average. The market capitalization of the company currently stands at $164.73M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
A total of 1 analysts have issued a hold rating and 0 have given it a buy rating. Brokers who have rated the stock have averaged $0.44 as their price target over the next twelve months.
With the price target of $6, Dawson James recently initiated with Buy rating for Zomedica Corp (AMEX: ZOM).
In other news, HEATON LARRY C II, CEO bought 100,000 shares of the company’s stock on May 26. The stock was bought for $19,090 at an average price of $0.19. Upon completion of the transaction, the CEO now directly owns 100,000 shares in the company, valued at $17000.0. An SEC document containing details of the transaction can be found on the SEC’s website. On May 25, Director POWERS JOHNNY D bought 100,000 shares of the business’s stock. A total of $19,340 was incurred on buying the stock at an average price of $0.19. This leaves the insider owning 1,600,000 shares of the company worth $0.27 million. A total of 1.55% of the company’s stock is owned by insiders.
Wednesday’s opening bell rang with an opening price of $0.1691 for Zomedica Corp (AMEX: ZOM). During the past 12 months, Zomedica Corp has had a low of $0.15 and a high of $0.34. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 17.12, and a quick ratio of 16.57. The fifty day moving average price for ZOM is $0.1712 and a two-hundred day moving average price translates $0.2041 for the stock.
The latest earnings results from Zomedica Corp (AMEX: ZOM) was released for Sep, 2023. According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at $0, inline with analysts’ expectations of $0. This compares to -$0.01 EPS in the same period last year. The net profit margin was -62.21% and return on equity was -5.64% for ZOM. The company reported revenue of $6.35 million for the quarter, compared to $4.78 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 32.89 percent. For the current quarter, analysts expect ZOM to generate $10.81M in revenue.
